Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)

Market Cap	28.24B
Revenue (ttm)	1.98B
Net Income (ttm)	-2.00B
Shares Out	984.87M
EPS (ttm)	-2.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	506,202
Open	13.18
Previous Close	13.06
Day's Range	12.90 - 13.26
52-Week Range	9.17 - 24.60
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Shanghai Junshi Biosciences

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People’s Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People’s Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,568
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2023, Shanghai Junshi Biosciences's revenue was 1.50 billion, an increase of 3.38% compared to the previous year's 1.45 billion. Losses were -2.28 billion, -4.38% less than in 2022.

Financial numbers in CNY